Funding · Company

Revalesio Corp

Tacoma, WABiotech & Pharma

Revalesio Corp of Tacoma, WA has disclosed $39M across 1 Form D offering filed with the SEC on Dec 16, 2025.

$39M

Total disclosed

Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$39M

Form D · Dec 16, 2025 ↗

Q4 2025 · 2 amendments, first filed Jun 9, 2022 · target $40M

Filing details

HeadquartersTacoma, WAIndustryBiotech & Pharma (Pharmaceuticals)SEC CIK0001552377Offerings on file1

Links

All SEC filings for this company ↗ revalesio.com ↗ More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →